Summary
The paper reports a study on the metabolic inversion of indoprofen (2-[4-(2-isoindolinyl-1-one)-phenyl]-propionic acid) following incubation of the drug with liver microsomes from non-induced and phenobarbital-induced rats.
The enantiomeric composition of the drug was determined after different incubation times of the racemate and the individual isomers. The S(+)/R(−) ratio was evaluated by densitometry following HPTLC separation of the R(+)-1-phenylethylamides.
After incubation of the racemate and the individual isomers, no detectable amounts of indoprofen catabolites were extracted from the acidified incubation mixture. An appreciable enrichment in the S(+) enantiomer was observed after incubation of both racemate and R(−)-indoprofen; the S(+)/R(−) ratio reached a maximum after 1 h. Values were higher in the case of induction. After incubation of S(+)-indoprofen, a small but statistically significant decrease of the S(+)/R(−) ratio was observed.
The increase of the S(+)-isomer concentration observed following incubation of R(−)-indoprofen can be ascribed to metabolic inversion by phenobarbital-inducible liver enzymes.
Similar content being viewed by others
References
Buttinoni A., Cuttica A., Franceschini J., et al. (1973): Pharmacological study on a new analgesic-anti-inflammatory drug: α-[4-(l-oxo-2-iso-indolinyl)-phenyl]-propionic acid or K. 4277. Arzneimittel Forsch, 23, 1100–1107.
Tosolini G.P, Moro E., Forgione A., Ranghieri M., Mandelli V. (1974): GLC determination of plasma levels of enantiomers of α-[4-(l-oxo-2-iso-indolinyl)phenyl] propionic acid. J. Pharm. Sci., 63, 1072–1076.
Tamassia V., Jannuzzo M.G., Mora E., Stegnjaich S., Groppi W., Nicolis F.B. (1984): Pharmacokinetics of the enantiomers of indoprofen in man. In: J. Clin. Pharmacol. Res., 4, 223–230.
Bjorkman S. (1985): Determination of the enantiomers of indoprofen in blood plasma by high-performance liquid chromatography after rapid derivatization by means of ethyl chloroformate. J. Chromatogr., 339, 339–346.
Jamali F. (1988): Pharmacokinetics of enantiomers of chiral non-steroidal anti-inflammatory drugs. Eur. J. Drug. Metab. Pharmacokinet., 13, 1–9.
Buttinoni A., Ferrari M., Colombo M., Ceserani R. (1983): Biological activity of indoprofen and its optical isomers. J. Pharm. Pharmacol., 35, 603–604
Hutt A.J., Caldwell J. (1983): The metabolic chiral inversion of 2-arylpropionic acids — a novel route with pharmacological consequences. J. Pharm. Pharmacol., 35, 693–704.
Caldwell J., Hutt A.J., Fournel-Gigleux S. (1988): The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences. Biochem. Pharmacol., 37, 105–144.
Ariens E.J. (1986): Chirality in bioactive agents and its pitfalls. Trends Pharmacol. Sci., 7, 200–205
Lombard A., Rossetti V., Buffa M., Cassone M.C. (1990): Stereospecific metabolism of indoprofen in rats. Med. Sci. Res., 18, 209–210.
Vangiessen G.T., Kaiser D.G. (1975): GLC determination of Ibuprofen [dl-2-(p-isobutylphenyl) propionic acid] enantiomers in biological specimens. J. Pharm. Sci., 64, 798–801.
Rossetti V., Lombard A., Buffa M. (1986): The HPTLC resolution of the enantiomers of some 2-arylpropionic acid anti-inflammatory drugs. J. Pharm. Biomed. Anal., 4, 673–676.
Rossetti V., Lombard A., Buffa M., Cassone M.C. (1986): Studies on the stereoisomeric inversion of ketoprofen in rats. IRCS Med. Sci., 14, 256–257.
Lee E.J.D., Williams K., Day R., Graham G., Champion D.: Stereoselective disposition of ibuprofen enantiomers in man. Br. J. Clin. Pharmacol., 19, 669–674.
Foumel S., Caldwell J. (1986): The metabolic chiral inversion of 2-phenylpropionic acid in rat, mouse and rabbit. Biochem. Pharmacol., 35, 4135–4159.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rossetti, V., Lombard, A., Buffa, M. et al. The in vitro metabolic inversion of R(−) to S(+) indoprofen. European Journal of Drug Metabolism and Pharmacokinetics 17, 183–186 (1992). https://doi.org/10.1007/BF03190143
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03190143